Raw milk poses serious infection risks with no added health benefits, pediatrician group warns - CIDRAP

We have become obsessed with the idea that screens are destroying human connection. The evidence seems to be everywhere. Each week headlines warn of teenagers addicted to phones, a loneliness epidemic and the dangers of AI. The release of The Social Reckoning leads us to ask, “How bad were those guys at Meta?” and then ultimately wonder, “How bad am I if I still use Instagram?” In our day-to-day, we observe workers eating lunch alone while scrolling and friends choosing online games over offline gatherings. But what if we are focusing on the wrong problem? The greatest threat to connection may not be technology itself. It may be our growing unwillingness to curiously, thoughtfully and openly communicate about the role technology plays in our lives. As a pediatrician, this issue often manifests in my clinic. Parents arrive with worries about their teens’ screen time. The parent will demand that their child “fess up” and reveal how many hours they waste on their phone every day. The atmosphere is immediately charged. The teen becomes defensive. The parent is frustrated. I often suggest that we start somewhere else.

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.